Article info
Extended report
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
- T Lequerré, Rheumatology Department, Rouen University Hospital & Inserm 905, 76031 Rouen, France; thierry.lequerre{at}univ-rouen.fr. Pierre Quartier, Unité d’Immunologie-Hématologie et Rhumatologie pédiatrique, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France; quartier{at}necker.fr
Citation
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
Publication history
- Accepted September 23, 2007
- First published October 18, 2007.
Online issue publication
May 01, 2023
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism